KORU Medical Systems Inc.

NASDAQ: KRMD · Real-Time Price · USD
4.11
-0.04 (-0.96%)
At close: Aug 21, 2025, 3:59 PM
4.11
0.00%
After-hours: Aug 21, 2025, 04:20 PM EDT

KORU Medical Systems Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
10.19M 9.64M 8.84M 8.18M 8.43M 8.2M 7.19M 7M 6.94M 7.39M 7.34M 7.76M 6.55M 6.24M 6.49M 6.04M 5.53M 5.43M
Cost of Revenue
3.72M 3.59M 3.28M 2.99M 2.95M 3.33M 3.08M 2.66M 3.05M 3.25M 3.27M 3.44M 3.2M 2.62M 2.66M 2.54M 2.32M 2.2M
Gross Profit
6.48M 6.05M 5.56M 5.19M 5.48M 4.87M 4.1M 4.34M 3.89M 4.15M 4.08M 4.32M 3.35M 3.62M 3.83M 3.5M 3.21M 3.23M
Operating Income
-312.65K -1.03M -1.59M -1.7M -1.19M -1.96M -2.2M -1.79M -3.22M -3.06M -2.51M -1.53M -3.61M -3.13M -2.11M -1.32M -1.38M -2.21M
Interest Income
78.95K n/a 80.46K 113K 214K 37.19K 169.23K 135.43K 131.17K 125.5K n/a 42.48K 3.57K n/a n/a n/a 9.95K 9.77K
Pretax Income
-189.51K -1.17M -1.56M -1.58M -988.72K -1.94M -2.02M -1.67M -3.1M -2.99M -2.41M -1.5M -3.63M -3.14M -1.44M -1.33M -1.37M -2.22M
Net Income
-206.87K -1.17M -1.56M -1.58M -988.72K -1.94M -7.47M -1.37M -2.5M -2.41M -1.98M -1.23M -2.92M -2.54M -1.07M -1.09M -1.12M -1.28M
Selling & General & Admin
5.38M 5.96M 5.83M 5.13M 5.32M 5.36M 5.01M 4.62M 5.3M 5.43M 4.76M 4.83M 5.53M 5.49M 4.88M 3.9M 4.09M 4.99M
Research & Development
1.19M 1.11M 1.11M 1.53M 1.13M 1.48M 1.29M 1.29M 1.6M 1.56M 1.64M 862.15K 1.3M 1.15M 949.93K 800.02K 386.88K 336.84K
Other Expenses
209.49K n/a 211.45K 227.78K 217.86K n/a n/a n/a n/a 213.12K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
6.79M 7.07M 6.94M 6.89M 6.45M 6.83M 6.3M 6.13M 7.11M 7.2M 6.59M 5.85M 6.96M 6.75M 5.94M 4.82M 4.59M 5.45M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.51M 10.66M 10.43M 9.88M 9.62M 10.16M 9.38M 8.79M 10.16M 10.45M 9.86M 9.29M 10.16M 9.37M 8.6M 7.36M 6.91M 7.64M
Income Tax Expense
17.36K n/a 2.89K n/a n/a n/a 5.45M -300.25K -600K -577.4K -434.66K -271.5K -710.26K -597.6K -375.84K -238.1K -245.32K -942.36K
Shares Outstanding (Basic)
46.19M 45.98M 45.91M 45.85M 45.81M 45.71M 45.67M 45.64M 45.61M 45.49M 45.37M 45.04M 44.92M 44.67M 44.57M 44.32M 44.49M 43.96M
Shares Outstanding (Diluted)
46.19M 45.98M 45.91M 45.85M 45.81M 45.71M 45.67M 45.64M 45.61M 45.49M 45.37M 45.04M 44.92M 44.67M 44.57M 44.32M 44.49M 43.96M
EPS (Basic)
n/a -0.03 -0.03 -0.03 -0.02 -0.04 -0.16 -0.03 -0.05 -0.05 -0.04 -0.03 -0.07 -0.06 -0.02 -0.02 -0.03 -0.03
EPS (Diluted)
n/a -0.03 -0.03 -0.03 -0.02 -0.04 -0.16 -0.03 -0.05 -0.05 -0.04 -0.03 -0.07 -0.06 -0.02 -0.02 -0.03 -0.03
EBITDA
-103.17K -810.29K -1.38M -1.48M -974.17K -1.73M -1.97M -1.58M -3.01M -2.84M -2.32M -1.37M -3.49M -3.02M -2M -1.21M -1.26M -2.1M
EBIT
-312.65K -1.03M -1.59M -1.7M -1.19M -1.96M -2.2M -1.79M -3.22M -3.06M -2.51M -1.53M -3.61M -3.13M -2.11M -1.32M -1.38M -2.21M
Depreciation & Amortization
209.49K 217.36K 211.45K 227.79K 217.86K 231.37K 228.34K 216.01K 212.92K 213.12K 187.66K 164.34K 125.88K 109.25K 113.31K 115.93K 118.42K 115.47K